Heaptalk, Jakarta — Indonesia-based health-tech startup Halodoc reportedly performs layoff of 350 employees, representing 20% job-cutting in the engineering and other departments. Halodoc’s layoffs are forced to be completed due to macroeconomic, political, and geopolitical obstacles.
The company claimed that the significant turbulence in macroeconomic, political, and geopolitical situations globally and domestically requires overall business players to continue to adjust, evaluate their business strategies regularly, and transform to ensure the proper approach to encounter industry dynamics.
In facing the current industrial climate, the company stated the importance of preparing a more responsive organization for future transformations, one of which is conducting the company’s rightsizing strategy.
In response to this job-cutting decision, the Vice President of Government Relations and Corporate Affairs of Halodoc, Adeline Hindarto, stated, “This step is not an easy decision, but we need to take it to ensure the company can grow sustainably. We have conducted this rightsizing with a mature consideration, which is expected to maintain the relevance and sustainability of Halodoc,”
Following the Halodoc layoff decision, this company will fulfill the rights of affected employees following applicable regulations and extend their health insurance until December 2024. From now on, Halodoc will continue to focus on improving services and expanding access to health services for the community with an orientation towards productivity and long-term business sustainability.
Established in 2016 in the health industry, Halodoc has achieved outstanding performance. This company has increased its business growth up to 20 times during the pandemic, with a significant contribution from the telemedicine service. In 2021, this platform obtained its active users of 20 million active users and reached users in multiple Indonesian regions, spanning Aceh, Nusa Tenggara, Maluku, and Papua.
In October 2023, Halodoc accomplished a new injection in a Series D funding round worth US$100 million, equal to Rp1.5 trillion. Astra International leads this investment round, with participation from Openspace, Novo Holdings, Denmark’s investor. Through this latest round, Astra’s total investment disbursed for this health-tech startup attained US$135 million (around Rp2 trillion).
“We thank and give our highest appreciation to overall employees who have contributed wholeheartedly, specifically in overcoming the Covid-19 pandemic,” concluded Adeline.
